Trends in breakthrough therapy designation
Trends in breakthrough therapy designation
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
This article analyses the first three years of the US Food and Drug Administration's breakthrough therapy designation programme, which was established to expedite development and approval of products to treat serious diseases.
Alternative Titles
Full title
Trends in breakthrough therapy designation
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1708904106
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1708904106
Other Identifiers
ISSN
1474-1776
E-ISSN
1474-1784
DOI
10.1038/nrd4717